Epsilon Healthcare Limited Share Price Other OTC
Equities
HDRPF
AU0000137598
Pharmaceuticals
Sales 2021 | 5.5M 3.63M 286M | Sales 2022 | 7.11M 4.7M 370M | Capitalization | 7.51M 4.96M 391M |
---|---|---|---|---|---|
Net income 2021 | -9M -5.94M -468M | Net income 2022 | -13M -8.58M -676M | EV / Sales 2021 | 3.26 x |
Net Debt 2021 | 2.1M 1.39M 109M | Net Debt 2022 | 2.34M 1.54M 122M | EV / Sales 2022 | 1.38 x |
P/E ratio 2021 |
-1.48
x | P/E ratio 2022 |
-0.38
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 60.39% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Sanghera
CEO | Chief Executive Officer | - | 11-20 |
Lin Li
AUD | Comptroller/Controller/Auditor | - | - |
Marcelo Mora
SEC | Corporate Secretary | 60 | 22/12/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Beasley
CHM | Chairman | - | 28/08/16 |
Stuart Cameron
BRD | Director/Board Member | - | 26/10/22 |
Xiao Cui
CHM | Chairman | - | 27/10/22 |
1st Jan change | Capi. | |
---|---|---|
+38.69% | 723B | |
+34.28% | 595B | |
-4.49% | 369B | |
+20.24% | 332B | |
+2.12% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.35% | 168B |